CONVERGENT VALIDITY OF NEW DISEASE ASSESSMENT INSTRUMENTS (DAI) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN RELATION TO SLEDAI-2K

被引：2
|
作者：
Narayanan, S. [1 ]
Collins, C. E. [2 ]
Busch, H. M. [3 ]
Gaylis, N. [4 ]
Hautamaki, E. [1 ]
Chatham, W. W. [5 ]
机构：
[1] Ipsos Healthcare, Washington, DC USA
[2] MedStar Washington Hosp Ctr, Washington, DC USA
[3] Sci & Res Inst, Jupiter, FL USA
[4] Arthritis & Rheumat Dis Specialities, Aventura, FL USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2004
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY104
引用
收藏
页码：A677 / A677
页数：1
相关论文
共 50 条
  • [31] Summarizing disease features over time - Part 2: The variability of SLEDAI-2K - Does it help in predicting outcomes in SLE?
    Ibanez, Dominique
    Urowitz, Murray B.
    Gladman, Dafna D.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S269 - S269
  • [32] Revising the SLEDAI-2K to Include Additional Constitutional Symptoms to More Accurately Assess Lupus Disease Activity
    Shah, Bhakti
    Anderson, Erik
    Mackay, Meggan
    Aranow, Cynthia
    Sansone, Marissa
    Hong, Joseph
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [33] Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study
    Anderson, Erik W.
    Sansone, Marissa
    Shah, Bhakti
    Kline, Myriam
    Franchin, Giovanni
    Aranow, Cynthia
    Mackay, Meggan
    [J]. LUPUS, 2024, 33 (08) : 840 - 850
  • [34] Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes
    Onishi, Akira
    Tsuji, Hideaki
    Takase, Yudai
    Nakakubo, Yuto
    Iwasaki, Takeshi
    Kozuki, Tomohiro
    Yoshida, Tsuneyasu
    Shirakashi, Mirei
    Onizawa, Hideo
    Hiwa, Ryosuke
    Kitagori, Koji
    Akizuki, Shuji
    Nakashima, Ran
    Yoshifuji, Hajime
    Tanaka, Masao
    Morinobu, Akio
    [J]. RHEUMATOLOGY, 2023, 62 (12) : 3909 - 3915
  • [35] Development and Assessment of User Satisfaction of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) Responder Index-50 (SRI-50) Website with Computer-Adaptive Training and Examination Modules
    Touma, Zahi
    Gladman, Dafna
    Mackinnon, Anne
    Carette, Simon
    Abu-Shakra, Mahmoud
    Askanase, Anca
    Nived, Ola
    Hanly, John
    Landolt-Marticorena, Carolina
    Tam, Lai-Shan
    Toloza, Sergio
    Nikpour, Mandana
    Riddell, Claire
    Steiman, Amanda
    Eder, Lihi
    Haddad, Amir
    Barber, Claire
    Urowitz, Murray B.
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1711 - 1711
  • [36] VALIDITY OF RETROSPECTIVE DISEASE-ACTIVITY ASSESSMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ARCESALINAS, A
    CARDIEL, MH
    GUZMAN, J
    ALCOCERVARELA, J
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 417 - 417
  • [37] Retrospective Validation of the 3 Laboratory Organ Systems of Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) Responder Index (SRI-50) Over 10 Years
    Touma, Zahi
    Gladman, Dafna D.
    Ibanez, Dominique
    Urowitz, Murray B.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S535 - S535
  • [38] Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE
    Ibañez, D
    Gladman, DD
    Urowitz, MB
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (05) : 824 - 827
  • [39] Identifying Response for the Systemic Lupus Erythematosus Disease Activity Glucocorticoid Index (SLEDAI-2KG)
    Touma, Zahi
    Gladman, Dafna D.
    Su, Jiandong
    Anderson, Nicole
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] Development and Initial Validation of a Novel Lupus Disease Activity Index to Account for Glucocorticoids: Sledai-2K Glucocorticoids Index (SGI)
    Touma, Zahi
    Gladman, Dafna D.
    Su, Jiandong
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345